Drug Screening Market is expected to reach up to USD 25.3 billion, at a CAGR of 16.3% during 2022-2031

The global drug screening market was valued at USD 5.6 billion in 2021 and it is expected to reach up to USD 25.3 billion by 2031, at a CAGR of 16.3% during the projection period.

Drug screening is the process of recognizing illicit and some recommended drugs in the blood, urine, and other biological samples. A drug screening process is also called the analysis and detection of performance-enhancing drugs consumed by professional athletes like steroids and HGH in order to improve stamina and performance at the time of the sport.

Read more about Drug Screening Market here: https://www.globalinsightservices.com/reports/drug-screening-market/

Some of the major illegal drugs include methamphetamines, methadone, and amphetamine. The rising incidence of such drugs consumptions across the world is the major concern being faced by many governments. For example, according to National Institute on Drug Abuse (NIDA), in 2010, an estimated 22.6 million of the population were illicit drug users in the U.S, which accounted for an estimated 8.9% of the total population of the country.

Market Trends and Drivers:

The key factor boosting the growth of the market is growing drug and alcohol consumption. Drug abuse and alcohol consumption are increasing worldwide. According to the World Drug Report 2021, in 2019, an estimated 275 million people across the globe aged 15-64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year. In the same year, drug use killed almost half a million people, while drug use disorders resulted in 18 million years of healthy life lost, mainly owing to opioids. Alcohol consumption has shown similar increases, with consequences witnessed in the growing incidence of impaired driving. The increasing consumption of illicit drugs & alcohol will further boost the development of drug screening products & services on the road, thereby driving the overall market growth.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS10273/

Market Segments:

- By Product & Services:
Drug Screening Product
Analytical Instruments
Rapid Testing Devices
Oral Fluid Testing Devices
Consumables
Drug Screening Service

- By Sample Type:
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others

- By End User:
Drug Testing Laboratories
Workplaces
Criminal Justice & Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
School and Colleges

Major Players in the Global Drug Screening Market:

The key players studied in the global drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan), LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference Laboratory (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Synens (France), Intoximeters (US), AccuSource (US), Cordant Health Solutions (US), Millennium Health (US).

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS10273/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.